German Cancer Prize
The German Cancer Prize is a German science prize . The prize, worth a total of 22,500 euros (as of 2020), is awarded by the German Cancer Society in three categories: experimental, clinical and translational cancer research. The donor is the German Cancer Foundation , the foundation of the German Cancer Society. It has been awarded since 1986.
Award winners
- 1986: Harald zur Hausen and Hansjörg Riehm (no separation into clinical and experimental part)
- 1987: Hartmut M. Rabes (experimental part) and Norbert Brock (clinical part)
- 1988: Paul Hermanek (clinical part), Franz Paul Gall (clinical part) and Volker Schirrmacher (experimental part)
- 1989: Manfred F. Rajewsky (experimental part), Klaus Havemann (clinical part), Dieter Hoelzer and Eckhard Thiel (group award, also clinical part)
- 1990: Franz Oesch (experimental part), Hansjörg Eibl (clinical part) and Clemens Unger (clinical part)
- 1991: Helmut Schoenenberger (clinical part), Thomas Blankenstein (clinical part) and Rolf Issels (experimental part)
- 1992: Walter Jonat (clinical part), Manfred Kaufmann (clinical part), Manfred Schwab (experimental part) and Rudolf Preußmann (experimental part)
- 1993: Carl Gottfried Schmidt (clinical part), Eberhard Scherer (clinical part), Fritz Anders / Annerose Anders (experimental part) and E. Gateff (experimental part)
- 1994: Jörg Rüdiger Siewert (clinical part), Adolf Gräßmann (experimental part) and Herbert J. Pfister (experimental part)
- 1995: Werner Franke (experimental part) and Claus Garbe (clinical part)
- 1996: Wolfgang Berdel (clinical part) and Peter H. Krammer (experimental part)
- 1997: Wolfgang Deppert (experimental part) and Volker Diehl (clinical part)
- 1998: Harald Stein (clinical part) and Axel Ullrich (experimental part)
- 1999: Peter M. Schlag (clinical part) and Walter Birchmeier (experimental part)
- 2000: Rolf Müller (experimental part) and Carsten Bokemeyer (clinical part)
- 2001: Hans-Joachim Schmoll (clinical part) and Ulf Rapp (experimental part)
- 2002: Klaus-Michael Debatin (clinical part) and Peter Lichter (experimental part)
- 2003: Wolfgang Schlegel (clinical part), Alfred Wittinghofer (experimental part) and Reinhard Dummer (translational part)
- 2004: Martin Eilers (experimental part), Rolf Sauer (clinical part), Jürgen Becker (translational part) and Otmar C. Wiestler (translational part)
- 2005: Thomas Wirth (experimental part), Richard Hautmann (clinical part), Wolfgang Steiner (clinical part), Bernd Dörken (translational part) and Claus Scheidereit (translational part)
- 2006: Jörg Michaelis (clinical part), Gerold Schuler (translational part), Thorsten Heinzel (experimental part) and Martin Göttlicher (experimental part)
2007
- Lutz Gissmann from the German Cancer Research Center (DKFZ) in Heidelberg for the invention of a vaccine against cervical cancer (cervical cancer ).
- Michael Weller , neurologist at the University of Tübingen , for leading a large therapy study in neuro-oncology
- Achim Leutz from the Max Delbrück Center for Molecular Medicine in Berlin, among other things for his research on the development of blood cancer .
2008
- Michael Stahl , senior internal physician at the Evangelical Huyssens Foundation (Essen) for his clinical and scientific contribution to the further development of interdisciplinary therapeutic strategies in the treatment of esophageal cancer ; clinical part.
- Edward K. Geissler , Head of Experimental Surgery at the University of Regensburg for his animal experiments on the antiangiogenic and tumor suppressive effects of the mTOR inhibitor sirolimus and for the prospective and randomized patient study based on the findings; translational part.
- Peter Friedl from the University Dermatology Clinic and the Rudolf Virchow Center for Experimental Biomedicine Würzburg for his work in the field of developing new imaging methods for investigating tumor invasion and his investigations into the mechanisms of tumor growth and metastasis; experimental part.
2009
- Günter Henze , director of the children's clinic at the Berlin Charité and spokesman for the Pediatric Oncology Competence Network for his scientific contribution to the further development of special therapy concepts for lymphoblastic leukemia in children; clinical part.
- Hans Konrad Müller-Hermelink , Director of the Institute for Pathology at the University of Würzburg for his basic research in the field of malignant lymphomas and his commitment to promoting interdisciplinary and translational structures in the scientific community; translational part.
- Nancy Hynes from the Friedrich Miescher Institute for Biomedical Research (Basel) for her work on the molecular pathogenesis of breast cancer , including the mechanisms of metastasis formation; experimental part.
2010
- Dirk Schadendorf , Director of the Clinic for Dermatology, Venereology and Allergology at the Essen University Hospital ( University of Duisburg-Essen ) for research into black skin cancer ; especially with regard to prognosis and therapeutic resistance; clinical part.
- Klaus Pantel , Director of the Institute for Tumor Biology at the University Medical Center Hamburg-Eppendorf for his work on so-called "sleeping tumor cells" and their role in late relapses and metastasis of cancer; translational part.
- Ivan Đikić from the Frankfurt Institute for Molecular Life Sciences at the Goethe University Frankfurt am Main for his fundamental work on the structure and function of the protein ubiquitin and its role in the development of cancer; experimental part.
2011
- Axel Hauschild , Department of Dermatology, Venereology and Allergology at the University Hospital Kiel, for his clinical research in the field of dermatological oncology, particularly for the treatment of skin cancers such as melanoma , as well as for its commitment to creating clinical guidelines ; clinical part.
- Heribert Jürgens , Head of the Clinic and Polyclinic for Pediatric and Adolescent Medicine, Pediatric Hematology and Oncology at the Münster University Hospital, for his clinical research on osteosarcomas , in particular with an Ewing tumor study, which led to an improvement in therapy, pathological understanding and the medical care for those affected; clinical part
- Bernd Kaina , Institute for Toxicology at the University Hospital Mainz, for his work in researching the genetic principles of action of chemotherapeutic agents in solid tumors. His work has led to an improvement in the predictions of the response to cancer therapies, particularly for glioblastoma ; experimental part.
2012
- Michael Bamberg , radiation oncologist at the University Hospital of Tübingen, for his "trend-setting studies on the therapy of patients with brain tumors "; clinical part.
- Florian Greten , II. Medical Clinic of the Technical University of Munich at the Klinikum rechts der Isar, for “Findings on the molecular pathology of colorectal cancer ”; experimental part.
- Charlotte Niemeyer , Center for Pediatric and Adolescent Medicine at the University of Freiburg, for research on understanding the development of myelodysplastic syndromes ; translational part.
2013
- Volker Heinemann , Medical Clinic and Polyclinic III of the University Hospital Munich, for the improvement of diagnosis and therapy of gastrointestinal tumors and Alexander Katalinic , Institute for Social Medicine and Epidemiology at the University Hospital Schleswig-Holstein, for the development of an interactive cancer atlas and for the scientific-epidemiological evaluation for Preparation of skin cancer screening; clinical part
- Lars Zender , Tübingen University Hospital, gastrointestinal oncology; for decoding certain cancer genes; experimental part
- Stefan Pfister , Center for Pediatric and Adolescent Medicine at the University of Heidelberg, for his research on childhood brain tumors, and Roman Thomas , Department of Translational Genomics at the University of Cologne, for deciphering certain gene mutations in bronchial carcinoma; translational part
2014
- Martin Schrappe , Kiel University Hospital, for individualized therapy of acute lymphoblastic leukemia (ALL); clinical part
- Simone Fulda , Goethe University Frankfurt, cell death mechanisms of various tumor types; translational part
- Christoph Klein , University Hospital Regensburg; new concepts of tumor progression and metastasis; experimental part
2015
- Günter Klöppel , Munich, work in the field of pathology and the characterization of tumors of the pancreas; clinical research
- Wolfgang Wick , Heidelberg, new therapy standards in the treatment of gliomas; translational research
- Lenhard Rudolph , Jena, role of telomeres in cancer and approaches for novel drugs against cancer; experimental research
2016
- Johannes Zuber , Vienna, development and application of optimized RNAi screening methods; experimental research
- Andreas von Deimling , Heidelberg, development of cancer-specific antibodies; translational research
- Stefan Bielack , Stuttgart, Anja Mehnert , Leipzig; clinical research
2017
- Petra Boukamp , Heidelberg, development of skin cancer, and Martin Lipp , Berlin, chemokine receptors; experimental research
- Guido Reifenberger , Düsseldorf, molecular causes of brain tumors; translational research
- Michael Hallek , Cologne, molecular tumor biology in CLL; clinical research
2018
- Hartmut Goldschmidt , Heidelberg, therapy of multiple myeloma; clinical research
- Michael Baumann , Heidelberg, individualized radiation therapy; translational research
- Thomas Brabletz , Erlangen, migrating cancer stem cells; experimental research
2019
- Michael Platten , Heidelberg and Mannheim; clinical research
- Roland Rad , Dieter Saur , Munich; experimental research
- Uğur Şahin , Mainz; translational research
2020
- Andreas du Bois , Essen-Mitte; clinical research
- Rita Schmutzler , Cologne; translational research
- Andreas Trumpp , Heidelberg; experimental research
Individual evidence
- ^ German Cancer Prize for child cancer researcher Prof. Henze. Science Information Service, accessed on March 21, 2009 .
- ↑ Cancer Prize for Dermatologists in Bochum. "Required reading online"; Institute for Journalism at the Technical University of Dortmund, accessed on March 1, 2010 .
- ↑ UKE researcher receives German Cancer Prize. Science Information Service, accessed on March 1, 2010 .
- ↑ Ivan Dikic receives the German Cancer Prize 2010. Science Information Service, accessed on March 1, 2010 .